Endocrinologia Clínica (Lúcio Vilar) - 6 Edição_Parte74

Prévia do material em texto

135.
136.
137.
138.
139.
140.
141.
Auriemma RS, Perone Y, Di Sarno A et al. Results of a single-center observational 10-year survey study on recurrence of
hyperprolactinemia after pregnancy and lactation. J Clin Endocrinol Metab. 2013; 98:372-9.
Pivonello R, De Martino MC, Auriemma RS et al. Pituitary tumors and pregnancy: the interplay between a pathologic
condition and a physiologic status. J Endocrinol Invest. 2014; 37:99-112.
Glezer A, Bronstein MD. Prolactinomas, cabergoline, and pregnancy. Endocrine. 2014; 47:64-9.
Karunakaran S, Page RC, Wass JA. The effect of the menopause on prolactin levels in patients with hyperprolactinaemia.
Clin Endocrinol (Oxf). 2001; 54:295-300.
Faje AT, Klibanski A. The treatment of hyperprolactinemia in postmenopausal women with prolactin-secreting
microadenomas: cons. Endocrine. 2015; 48:79-82.
Mallea-Gil MS, Manavela M, Alfieri A et al. Prolactinomas: evolution after menopause. Arch Endocrinol Metab. 2016;
60:42-6.
Iacovazzo D, De Marinis L. Treatment of hyperprolactinemia in postmenopausal women: pros. Endocrine. 2015; 48:76-8.
	Endocrinologia Clínica (Lúcio Vilar) - 6ª Edição